Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis
NCT04022096
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
351
Enrollment
INDUSTRY
Sponsor class
Conditions
Healed Erosive Esophagitis
Interventions
DRUG:
Tegoprazan 25mg QD
DRUG:
Lansoprazole 15mg QD
Sponsor
HK inno.N Corporation